
Surmodics SRDX
Quarterly report 2025-Q2
added 08-08-2025
Surmodics PEG Ratio 2011-2026 | SRDX
Annual PEG Ratio Surmodics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.659 | -49.2 | -0.58 | 2.55 | 20.6 | 0.309 | 0.882 | -1.61 | -1.29 | 1.36 | -1.51 | 0.298 | 0.178 | -0.375 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.6 | -49.2 | -1.98 |
PEG Ratio of other stocks in the Diagnostics research industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-3.07 | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
-0.0104 | - | -6.19 % | $ 10.5 M | ||
|
Agilent Technologies
A
|
2.05 | $ 116.83 | 2.6 % | $ 35.5 B | ||
|
Biocept
BIOC
|
-0.000363 | - | -13.05 % | $ 7.29 M | ||
|
DermTech
DMTK
|
-0.847 | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
-0 | - | -8.98 % | $ 14.8 K | ||
|
Castle Biosciences
CSTL
|
0.278 | $ 25.13 | 1.19 % | $ 698 M | ||
|
Exact Sciences Corporation
EXAS
|
-0.798 | - | - | $ 19.8 B | ||
|
Danaher Corporation
DHR
|
210 | $ 196.66 | 2.95 % | $ 140 B | ||
|
CareDx, Inc
CDNA
|
-1.49 | $ 18.02 | 1.98 % | $ 960 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
2.29 | - | - | $ 562 M | ||
|
DexCom
DXCM
|
1.12 | $ 65.77 | 4.21 % | $ 25.7 B | ||
|
Akumin
AKU
|
0.0277 | - | -17.87 % | $ 25.9 M | ||
|
Fulgent Genetics
FLGT
|
-0.00389 | $ 16.25 | 2.14 % | $ 491 M | ||
|
Heska Corporation
HSKA
|
3.41 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.00137 | - | -20.0 % | $ 1.06 M | ||
|
Burning Rock Biotech Limited
BNR
|
0.283 | $ 15.84 | -1.55 % | $ 170 M | ||
|
Guardant Health
GH
|
-3.43 | $ 94.49 | 1.28 % | $ 11.8 B | ||
|
Co-Diagnostics
CODX
|
-0.000246 | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Accelerate Diagnostics
AXDX
|
0.114 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
0.0591 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-0.383 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
62.6 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-0.00417 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
9.49 | $ 176.18 | 3.87 % | $ 8.73 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
-2.1 | - | - | $ 10.7 B | ||
|
Motus GI Holdings
MOTS
|
-0.069 | - | -34.28 % | $ 263 K | ||
|
Biodesix
BDSX
|
1.09 | $ 14.28 | -1.72 % | $ 1.85 B | ||
|
ICON Public Limited Company
ICLR
|
1.16 | $ 108.06 | 0.84 % | $ 8.91 B | ||
|
Interpace Biosciences
IDXG
|
-0.00238 | $ 1.99 | -0.25 % | $ 8.8 M | ||
|
OpGen
OPGN
|
0.00227 | - | -16.95 % | $ 1.54 M | ||
|
Illumina
ILMN
|
2.16 | $ 128.36 | 1.52 % | $ 20.4 B | ||
|
PerkinElmer
PKI
|
-10.2 | - | -0.91 % | $ 14.7 B | ||
|
IQVIA Holdings
IQV
|
1.57 | $ 174.45 | 2.3 % | $ 30 B | ||
|
Quotient Limited
QTNT
|
0.0889 | - | -11.32 % | $ 1.1 M | ||
|
QIAGEN N.V.
QGEN
|
3.43 | - | - | $ 10.6 B | ||
|
Laboratory Corporation of America Holdings
LH
|
22.7 | $ 275.15 | 2.22 % | $ 22.9 B | ||
|
Anixa Biosciences
ANIX
|
-0 | $ 2.66 | -1.3 % | $ 86.3 K | ||
|
Lantheus Holdings
LNTH
|
-0.338 | $ 80.09 | 2.57 % | $ 5.41 B | ||
|
Biomerica
BMRA
|
-0.0105 | $ 2.16 | - | $ 4.96 M | ||
|
BioNano Genomics
BNGO
|
-0.000157 | $ 1.17 | 0.02 % | $ 6.37 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.0368 | - | - | $ 9.42 M | ||
|
Medpace Holdings
MEDP
|
0.906 | $ 523.59 | 2.96 % | $ 15.1 B | ||
|
Mettler-Toledo International
MTD
|
4.59 | $ 1 323.64 | 4.22 % | $ 27.3 B | ||
|
Myriad Genetics
MYGN
|
-0.00983 | $ 4.86 | 2.43 % | $ 450 M | ||
|
Celcuity
CELC
|
-0.769 | $ 116.44 | 0.76 % | $ 5.44 B | ||
|
NeoGenomics
NEO
|
0.0904 | $ 8.3 | 2.98 % | $ 1.06 B | ||
|
Neogen Corporation
NEOG
|
0.00738 | $ 10.53 | 5.46 % | $ 2.28 B | ||
|
Natera
NTRA
|
-0.401 | $ 211.61 | 1.12 % | $ 20.8 B | ||
|
National Research Corporation
NRC
|
-7.14 | $ 17.63 | 3.43 % | $ 395 M |